Showing codes 43602-266-30 Hydromorphone Hydrochloride — 43602-308-05 Lisdexamfetamine Dimesylate

43602-266-30 - Hydromorphone Hydrochloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-266-30)
Usage type: ORAL
HTML TXT

43602-267-05 - Hydromorphone Hydrochloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-267-05)
Usage type: ORAL
HTML TXT

43602-267-30 - Hydromorphone Hydrochloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-267-30)
Usage type: ORAL
HTML TXT

43602-268-05 - Hydromorphone Hydrochloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-268-05)
Usage type: ORAL
HTML TXT

43602-268-30 - Hydromorphone Hydrochloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-268-30)
Usage type: ORAL
HTML TXT

43602-269-05 - Hydromorphone Hydrochloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-269-05)
Usage type: ORAL
HTML TXT

43602-269-30 - Hydromorphone Hydrochloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-269-30)
Usage type: ORAL
HTML TXT

43602-283-05 - Potassium Chloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-283-05)
Usage type: ORAL
HTML TXT

43602-283-30 - Potassium Chloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-283-30)
Usage type: ORAL
HTML TXT

43602-284-05 - Potassium Chloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-284-05)
Usage type: ORAL
HTML TXT

43602-284-30 - Potassium Chloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-284-30)
Usage type: ORAL
HTML TXT

43602-285-05 - Potassium Chloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-285-05)
Usage type: ORAL
HTML TXT

43602-285-30 - Potassium Chloride
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-285-30)
Usage type: ORAL
HTML TXT

43602-291-05 - Icosapent Ethyl
Firm: Ascent Pharmaceuticals, Inc
Package Description: 500 CAPSULE in 1 BOTTLE (43602-291-05)
Usage type: ORAL
HTML TXT

43602-291-30 - Icosapent Ethyl
Firm: Ascent Pharmaceuticals, Inc
Package Description: 30 CAPSULE in 1 BOTTLE (43602-291-30)
Usage type: ORAL
HTML TXT

43602-294-05 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-294-05)
Usage type: ORAL
HTML TXT

43602-294-07 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-294-07)
Usage type: ORAL
HTML TXT

43602-294-30 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-294-30)
Usage type: ORAL
HTML TXT

43602-295-05 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-295-05)
Usage type: ORAL
HTML TXT

43602-295-07 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-295-07)
Usage type: ORAL
HTML TXT

43602-295-30 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-295-30)
Usage type: ORAL
HTML TXT

43602-296-05 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-296-05)
Usage type: ORAL
HTML TXT

43602-296-07 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-296-07)
Usage type: ORAL
HTML TXT

43602-296-30 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-296-30)
Usage type: ORAL
HTML TXT

43602-297-05 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-297-05)
Usage type: ORAL
HTML TXT

43602-297-07 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-297-07)
Usage type: ORAL
HTML TXT

43602-297-30 - Paliperidone
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-297-30)
Usage type: ORAL
HTML TXT

43602-306-01 - Lisdexamfetamine Dimesylate
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 100 CAPSULE in 1 BOTTLE (43602-306-01)
Usage type: ORAL
HTML TXT

43602-307-05 - Lisdexamfetamine Dimesylate
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 CAPSULE in 1 BOTTLE (43602-307-05)
Usage type: ORAL
HTML TXT

43602-307-60 - Lisdexamfetamine Dimesylate
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 60 CAPSULE in 1 BOTTLE (43602-307-60)
Usage type: ORAL
HTML TXT

43602-308-05 - Lisdexamfetamine Dimesylate
Firm: Ascent Pharmaceuticals, Inc.
Package Description: 500 CAPSULE in 1 BOTTLE (43602-308-05)
Usage type: ORAL
HTML TXT

Current Page # is: 5277
Ones	0	1	2	3	4	5	6	7	8	9
Tens	0	1	2	3	4	5	6	7	8	9
Hundreds	0	1	2	3	4	5	6	7	8	9
Thousands	0	1	2	3	4	5	6	7	8	9
Tens of Thousands	0	1	2